SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
SIMCERE PHARMACEUTICALS
(NYSE:SCR Last Sale: 9.48 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NYSE: (SCR : $9.48)
$588 million Market Cap at September 12, 2013
Drugs SubIndustry up .00% / Health Industry up .00% Today

No. 699-18 Xuan Wu Avenue, Xuan Wu District Research Report Earnings Snapshot - Last 11/14/17
Jiangsu Province Fact Sheet
Nanjing, 210042 Financial Statements
China Peer Comparison
Phone: (86) 25-8547-6400 Annual Reports

Jinsheng Ren, Chmn./CEO, Frank Zhigang Zhao, CFO
Chinese drug manufacturer. ADR's = 2-for-1. IPO at $14.50 April 19, 2007. Raised $226.6 million, selling 15.6 million shares, 25% of the outstanding. Lead Manager: Goldman Sachs.
Historical Charts    Technical Analysis
No Historical Data available for SCR

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common SCR $9.48 $ 0 $9.48 $9.57 1,400 $7.25 $9.77 62,020
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10126
Common Stock $587,950

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2025 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex